5240 articles
Andrew Krivoshik, SVP, and Oncology Therapeutic Area Head at Astellas Pharma US discusses the overall survival findings from the Phase 3 PROSPER trial i...
Ayman Al-Hendy, MD, discusses the recent FDA approval of AbbVie’s ORIAHNN™ (elagolix, estradiol, and norethindrone acetate capsules; elagolix capsul...
Lane Conger Maples, VP of Client Experience at Bridge Connector, a company offering interoperability and integration solutions discusses the current sta...
Karim Richard Masri, a Rheumatologist at the Bon Secours Rheumatology center in Richmond, VA discusses new data released by Horizon Therapeutics at the ...
Michael Korn, Chief Medical Officer at Caris Life Sciences®, discusses the data presentation from the American Society of Clinical Oncology, (ASCO20) V...
Chadi Nabhan, Chairman of Precision Oncology Alliance™ at Caris Life Sciences® and Dr. Learn more on Health Professional Radio.
Nicholas, MD, MPH, discusses multiple sclerosis (MS) and MS relapses. She talks about the recently FDA approved ZEPOSIA® (ozanimod) a new oral therap...
Rollie Carlson, CEO of Immunexpress discusses the development and commercialization plans for SeptiCyte® RAPID. SeptiCyte® RAPID is a test that quan...
Craig Rayner, president of Certara’s Integrated Drug Development and Strategic Consulting Services discusses the COVID-19 Pharmacology Online Resource...
Justin Williams, founder and CEO of Noteworth, a healthcare delivery platform, discusses the biggest issues facing telehealth today, particularly in rur...